BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial
- DOI
- 10.1186/s13045-025-01713-2
- Published
- 2025-05-19
- Container
- Journal of Hematology & Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13045-025-01713-2,
title = {BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial},
author = {Hao Yao and Shi-hui Ren and Lin-hui Wang and Ming-qiang Ren and Jiao Cai and Dan Chen and Ying He and Si-han Lai and Bai-tao Dou and Meng-jiao Li and Yan-ling Li and Ya-li Cen and Alex H. Chang and Yi Su and Ling Qiu and Fang-yi Fan},
year = {2025},
journal = {Journal of Hematology \& Oncology},
doi = {10.1186/s13045-025-01713-2},
url = {https://doi.org/10.1186/s13045-025-01713-2}
}RIS
TY - JOUR TI - BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial AU - Hao Yao AU - Shi-hui Ren AU - Lin-hui Wang AU - Ming-qiang Ren AU - Jiao Cai AU - Dan Chen AU - Ying He AU - Si-han Lai AU - Bai-tao Dou AU - Meng-jiao Li AU - Yan-ling Li AU - Ya-li Cen AU - Alex H. Chang AU - Yi Su AU - Ling Qiu AU - Fang-yi Fan PY - 2025 JO - Journal of Hematology & Oncology DO - 10.1186/s13045-025-01713-2 UR - https://doi.org/10.1186/s13045-025-01713-2 ER -
APA
Yao, H., Ren, S., Wang, L., Ren, M., Cai, J., Chen, D., He, Y., Lai, S., Dou, B., Li, M., Li, Y., Cen, Y., Chang, A. H., Su, Y., Qiu, L., & Fan, F. (2025). BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-025-01713-2
Source records
- crossref · retrieved 2026-09-25T16:50:11.512Z